Placebo double encapsulated oral transplant of fecal microbiota, Double encapsulated oral transplant of fecal microbiota
APHP180591
Phase 3 small_molecule active
Quick answer
Placebo double encapsulated oral transplant of fecal microbiota, Double encapsulated oral transplant of fecal microbiota for Adults Non Diabete Remission (NDR) Type 2 Diabete (T2D) patients 1 to 5 years after bariatric surgery is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Adults Non Diabete Remission (NDR) Type 2 Diabete (T2D) patients 1 to 5 years after bariatric surgery
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active